Two independent breakthroughs promise to extend high‑resolution protein analysis: a single‑molecule peptide sequencing method that converts peptides into amplifiable DNA barcodes and a separate Stanford‑led protein‑sequencing advance reported in Nature Biotechnology. The reverse‑translation approach maps peptides to DNA tags so individual amino acid sequences become readable by established DNA sequencing workflows, enabling single‑molecule sensitivity. The Stanford method complements that capability by improving throughput and accuracy for protein identification, yielding data that could accelerate biomarker discovery and proteome‑scale interrogation for drug target validation. Both advances reduce reliance on bulk mass spectrometry and offer scalable paths for proteomics in translational research and clinical diagnostics.